AusBiotech is calling for member contributions for the September 2023 edition of the Australasian Biotechnology journal.
AusBiotech is welcoming abstracts from valued members on advancing Australian capabilities with themes including medicines and manufacturing, and taking Australian Inc global, with articles sought on new approaches, contributions or analyses to include in the September 2023 edition of the Australasian Biotechnology Journal.
The journal will also feature a sneak peek into October’s premier annual conferences, AusBiotech 2023 and AusBioInvest 2023, where local and global thought leaders discuss the latest research, technologies, challenges and market access strategies, and what Australia is bringing to the life sciences world-stage.
Australasian Biotechnology is AusBiotech’s official biannual journal published in September and April. Its contributions are written by the sector, for the sector. Contributions can include innovative medicine development, mass manufacturing, Australian strengths and successes on the world stage, and approaches to strengthening Australia’s end-to-end life sciences value chain.
With its informed and authoritative editorials, Australasian Biotechnology is a highly-effective communications vehicle for those wanting to reach stakeholders in the life sciences sector. The journal is mailed on a name-and-title basis to more than 3,000 AusBiotech members and investors and published digitally. Readership includes companies, government and university departments, research institutes, biotechnology and professional services providers nationally, and in key overseas markets.
Abstracts should be 200 words and can be sent to Communications by 20 July 2023.
If your abstract is accepted, the full article will be required on or before 3 August 2023. Article lengths are approximately 500 words (1 page) or 1,000 words (2 pages). High-resolution photos to accompany articles are encouraged.
Articles are an AusBiotech member-benefit, however, there is limited space and so they are not guaranteed to be included.
Abstracts are welcomed on research, business news, and sector trends for consideration at any time of the year.